Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -838,094 | -335,534 | 93,289 | N/A | 61,219 |
| Depreciation Amortization | 37,541 | 245,980 | 23,848 | N/A | 20,063 |
| Income taxes - deferred | 78,248 | 59,260 | 8,853 | N/A | -6,212 |
| Other Working Capital | -15,453 | -173,311 | -37,953 | N/A | 13,067 |
| Loans | -957 | 0 | -3,726 | N/A | -6,399 |
| Other Operating Activity | 975,748 | 360,622 | 38,007 | 0 | 20,571 |
| Operating Cash Flow | $237,033 | $157,017 | $122,318 | $N/A | $102,309 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,124 | -14,004 | -9,204 | N/A | -12,633 |
| Net Acquisitions | N/A | N/A | 92,419 | N/A | N/A |
| Purchase Of Investment | -1,545,533 | -2,228,300 | -414,949 | N/A | -488,867 |
| Sale Of Investment | 2,234,268 | 1,392,185 | 283,176 | N/A | 518,411 |
| Net Loans | 504,180 | -331,173 | -689,744 | N/A | -640,858 |
| Other Investing Activity | 95,914 | 11,635 | -978 | 0 | -5,808 |
| Investing Cash Flow | $1,273,705 | $-1,169,657 | $-739,280 | $N/A | $-629,755 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -113,877 | -15,822 | 631,883 | N/A | -168,336 |
| Debt Issued | 220,000 | 781,906 | 2,246,244 | N/A | 1,204,777 |
| Debt Repayment | -608,930 | -742,733 | -2,133,187 | N/A | -1,395,513 |
| Common Stock Issued | 0 | 304,390 | 3,592 | N/A | 3,411 |
| Dividend Paid | -6,733 | -20,487 | -16,243 | N/A | -1,736 |
| Other Financing Activity | 0 | -22,925 | -36,504 | 0 | -20,042 |
| Financing Cash Flow | $-1,084,757 | $956,964 | $632,875 | $N/A | $565,566 |
| Beginning Cash Position | 138,802 | 194,478 | 178,565 | N/A | 93,187 |
| End Cash Position | 564,783 | 138,802 | 194,478 | N/A | 131,307 |
| Net Cash Flow | $425,981 | $-55,676 | $15,913 | $N/A | $38,120 |
| Free Cash Flow | |||||
| Operating Cash Flow | 237,033 | 157,017 | 122,318 | N/A | 102,309 |
| Capital Expenditure | -15,124 | -13,980 | -14,671 | N/A | -12,901 |
| Free Cash Flow | 221,909 | 143,037 | 107,647 | 0 | 89,408 |